UCL Queen Square Institute of Neurology


Eleonora Lugarà

Eleonora Lugarà is the Translational Research Manager for Queen Square Institute of Neurology.

Eleonora obtained her PhD in Neuroscience from UCL, where she carried out research on both basic science and gene therapies for epilepsy. She is a co-leader investigator in the VIBES clinical study funded by ERUK in collaboration with Imperial College London to detect biomarkers of seizures. Before re-joining UCL, Eleonora worked for UCB pharma company in gene therapy development and early phase drug discovery where she was part of the epilepsy team.

Together with Professor Dimitri Kullmann (Deputy Director for Enterprise, Translation and Advanced Therapies), Eleonora facilitates the activities around translational research for all investigators at the Institute of Neurology.

Contact Eleonora to:

  • Explore whether your science has unmapped translational opportunities. This applies to any neurological disease, in any area of neuroscience and modality-agnostic: advanced therapies (gene and cell therapy), biologics (antibodies, ASOS, RNAi…), devices (apps, biomarkers, software development, assays...), drug repurposing, small molecules, regenerative medicine (biomaterials)
  • Understand where your research sits along the translational path and what to do to progress to the next phase(s)
  • Identify funding opportunities via grant applications or with commercial partners (in collaboration with the UCL Translational Research Office)
  • Protect your ideas by filing a patent or understanding licensing opportunities (with UCL tech transfer office “UCLBusiness”)
  • Consider forming a spin-out company to accelerate innovation (with UCL Tech Fund)
  • Facilitate the communication with key stakeholders for observational or clinical trials (with the Joint Research Office and Research Services)
  • Explore careers outside academia
  • Donate to Queen Square Institute of Neurology

Eleonora Lugara'